Lanzhou Foci Pharmaceutical: Announcement of Annual Equity Distribution Implementation in 2023
Lanzhou Foci Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
Foci Pharmaceutical: Announcement on the acquisition of 60% of the shares of Guangdong Foci Puze Pharmaceutical Co., Ltd. and related transactions
Foci Pharmaceutical: Announcement on the release of the pledge of some of the controlling shareholders\' shares
Foci Pharmaceutical: Announcement on Gansu State-owned Assets Investment Group Co., Ltd.\'s offer to acquire the company\'s shares and complete the transfer
Foci Pharmaceutical: Announcement on the progress of Gansu SDIC\'s anti-monopoly review and tender offer through the State Administration of Market Supervision and Administration
Foci Pharmaceutical: Announcement on the progress of the tender offer
Foci Pharmaceuticals: Simplified Report on Changes in Equity
Foci Pharmaceuticals: Summary of the Teaser Takeover Report (Revised Draft)
Forci Pharmaceutical: Announcement on the progress of the free transfer of the controlling shareholder\'s shares to the Lanzhou State-owned Assets Administration Commission
Forci Pharmaceutical: An indicative announcement on the free transfer of the controlling shareholder\'s shares to the Lanzhou State-owned Assets Administration Commission
Foci Pharmaceutical: Announcement on the progress of the tender offer
Foci Pharmaceutical: Prompt announcement on the implementation of the 2022 equity distribution leading to the adjustment of tender purchase prices
Foci Pharmaceutical: 2022 Annual Equity Distribution Implementation Notice
Foci Pharmaceutical: Announcement on the progress of the tender offer
Foci Pharmaceutical: Announcement on the progress of the tender offer
Foci Pharmaceutical: Prompt Announcement on Receiving a Summary of the Tender Takeover Report
Foci Pharmaceuticals: Simplified Report on Changes in Equity
Foci Pharmaceutical: Announcement on the cancellation of the pledge and re-pledge of some of the shares of the controlling shareholder
Foci Pharmaceutical: Announcement on the controlling shareholder's equity pledge
No Data
No Data